Literature DB >> 32687440

Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.

Kamil F Faridi1,2, Hector Tamez2, Jordan B Strom2, Yang Song3, Neel M Butala4, Changyu Shen2, Eric A Secemsky2, Laura Mauri3,5, Jeptha P Curtis1, C Michael Gibson2,3, Robert W Yeh2,4,3.   

Abstract

Entities:  

Keywords:  administrative claims, healthcare; clinical trial; coronary artery disease

Year:  2020        PMID： 32687440      PMCID： PMC7374757          DOI： 10.1161/CIRCULATIONAHA.120.047729

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

1.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Authors:  Laura Mauri; Dean J Kereiakes; Robert W Yeh; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Sharon-Lise T Normand; Eugene Braunwald; Stephen D Wiviott; David J Cohen; David R Holmes; Mitchell W Krucoff; James Hermiller; Harold L Dauerman; Daniel I Simon; David E Kandzari; Kirk N Garratt; David P Lee; Thomas K Pow; Peter Ver Lee; Michael J Rinaldi; Joseph M Massaro
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study.

Authors:  Jordan B Strom; Yuansong Zhao; Kamil F Faridi; Hector Tamez; Neel M Butala; Linda R Valsdottir; Jeptha Curtis; J Matthew Brennan; Changyu Shen; Mike Boulware; Jeffrey J Popma; Robert W Yeh
Journal:  Circ Cardiovasc Interv       Date:  2019-11-07       Impact factor: 6.546

3.  Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.

Authors:  Jordan B Strom; Hector Tamez; Yuansong Zhao; Linda R Valsdottir; Jeptha Curtis; J Matthew Brennan; Changyu Shen; Jeffrey J Popma; Laura Mauri; Robert W Yeh
Journal:  Am Heart J       Date:  2019-03-06       Impact factor: 4.749
  3 in total
  1 in total

1.  Prognosis of Claims- Versus Trial-Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting.

Authors:  Neel M Butala; Kamil F Faridi; Eric A Secemsky; Yang Song; Jeptha Curtis; Charles Michael Gibson; Dhruv Kazi; Changyu Shen; Robert W Yeh
Journal:  J Am Heart Assoc       Date:  2021-03-06       Impact factor: 5.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.